Strides Emerging Markets Limited

Strides Emerging Markets Limited - pharma in Bangalore, Karnataka, India. Directors, charges & compliance details.
CIN U24132KA2012PLC064214 Incorporated 01 June 2012 ROC Bangalore HQ Bangalore, Karnataka, India
Merged Public Limited Company pharma
Data last updated
Revenue · FY 2020
₹39.32 Cr
▲ 735% YoY
Net profit · FY 2020
₹8.54 Cr
Net margin 21.7%
EBITDA · FY 2020
-₹5.55 Cr
EBITDA margin -14.1%
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹5.63 Cr
Issued & subscribed
Satisfied charges
₹15 Cr
No open charges
Company age
14 yrs
Est. 2012
Employees · EPFO
199
Provident fund records

About Strides Emerging Markets Limited

Data last updated:

Strides Emerging Markets Limited was a public limited company based in Bangalore, Karnataka, India, operated as a subsidiary of Strides Pharma (Cyprus) Limited, Cyprus. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 June 2012.

The company was registered with the Registrar of Companies (ROC), Bangalore, under CIN U24132KA2012PLC064214. Its GSTIN is 29AARCS5667D1ZQ (Karnataka).

The company had an authorised share capital of ₹10 Cr and a paid-up capital of ₹5.63 Cr. It was formerly known as Strides Emerging Markets Private Limited. It was led by directors including Krishnan Tirucherai Parthasarathy and Venkata Seetharama Raju Pakalapati.

Its last annual general meeting (AGM) was held on 23 September 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office was at Strideshouse Bilekahalli Bannerghattaroad, Bangalore, Karnataka, India – 560076.

As per the financials filed for FY 2020, the company reported a revenue of ₹39.32 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹8.54 Cr (net margin 21.7%) and EBITDA of -₹5.55 Cr (EBITDA margin -14.1%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years.

The company had about 199 employees on its provident fund (EPFO) records before it was dissolved.

As per MCA filings, the company had satisfied charges of ₹15 Cr on record. Court records list 2 cases involving the company, including 2 filed by the company; 1 case is pending.

The last known website on record is strides.com.

Company Details of Strides Emerging Markets Limited
CIN U24132KA2012PLC064214
Registration Number 064214
Incorporation Date 01 June 2012
ROC Bangalore
Listing Status Unlisted
Company Status Amalgamated
Date of Last AGM 23 September 2020
Date of Balance Sheet 31 March 2020
Parent Company Strides Pharma (Cyprus) Limited, Cyprus
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
  • Registered Address
    Strideshouse Bilekahalli Bannerghattaroad, Bangalore, Karnataka, India – 560076
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Strides Emerging Markets Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Strides Emerging Markets Limited report

Financials, compliance, directors, charges, ownership and filings for Strides Emerging Markets Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Strides Emerging Markets Limited

The main business activity of Strides Emerging Markets is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Strides Emerging Markets Limited FY 2020 filings available

Strides Emerging Markets Limited reported revenue of ₹39.32 Cr (up 735% YoY) for FY 2020.

Revenue · FY 2020
₹39.32 Cr ▲ 735%
Net profit · FY 2020
₹8.54 Cr margin 21.7%
EBITDA · FY 2020
-₹5.55 Cr margin -14.1%

Compounded Annual Growth Rate (CAGR) of Strides Emerging Markets Limited

Revenue CAGR growth
1 year
▲ 735%
3 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▲ 46%
3 years · compounded
▲ 7%

Revenue has grown at a compounded annual rate (CAGR) of 9% over three years, including 735% growth in the latest year. EBITDA rose 46% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Strides Emerging Markets Limited

MetricsFY 2019-20FY 2018-19FY 2017-18FY 2016-17FY 2015-16
Profit and Loss Statement
Revenue from Operations₹39.32 Cr••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA-₹5.55 Cr••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹8.54 Cr••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Strides Emerging Markets Limited

MetricsFY 2019-20FY 2018-19FY 2017-18FY 2016-17FY 2015-16
Profitability
EBITDA Margin-14.1%••••••••••••••••
Net Profit Margin21.7%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Strides Emerging Markets are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Strides Emerging Markets Limited

Strides Emerging Markets Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Stellar Formulations Industries Private Limited₹39.96 Cr (FY 2025)••••••••11.0%••••Vadodara, Gujarat, India
Dolf Industries Private Limited₹39.95 Cr (FY 2025)••••••••••••Dabhoi, Gujarat, India
Zenith Enzymatic Drugs Private Limited₹39.93 Cr (FY 2024)••••••••6.0%••••Pune, Maharashtra, India
Vanelloid Private Limited₹39.6 Cr (FY 2024)••••••••11.0%••••Ludhiana, Punjab, India
MMC Health Care Limited₹39.6 Cr (FY 2024)••••••••-17.0%••••Chennai, Tamil Nadu, India
Strides Emerging Markets Limited this company₹39.32 Cr (FY 2020)••••••••735.0%••••Bangalore, Karnataka, India
Giyaan Pharma Private Limited₹39.31 Cr (FY 2024)••••••••16.0%••••Hyderabad, Telangana, India
Embiotic Laboratories Private Limited₹39.29 Cr (FY 2025)••••••••3.0%••••Bangalore, Karnataka, India
Forma Chem Pvt Ltd₹39.25 Cr (FY 2025)••••••••-46.0%••••Kolkata, West Bengal, India
Jo Pharma Limited₹39.24 Cr (FY 2025)••••••••-10.0%••••Delhi, India
Civentichem (India) Private Limited₹39.15 Cr (FY 2024)••••••••-52.0%••••Hyderabad, Telangana, India

Peers are the five companies nearest above and the five nearest below Strides Emerging Markets by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Strides Emerging Markets Limited

Strides Emerging Markets Limited is audited by GNANOBA & BHAT for the financial year 2020.

NameStatusAppointment DateCessation Date
GNANOBA & BHATLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Strides Emerging Markets Limited

Strides Emerging Markets has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Krishnan Tirucherai ParthasarathyDirector30 Jan 20188 Years 8 MonthsAs last reported
Venkata Seetharama Raju PakalapatiDirector11 May 201610 Years 4 MonthsAs last reported
Umesh Pralhadrao KaleDirector11 May 201610 Years 4 MonthsAs last reported

Ownership and Shareholding of Strides Emerging Markets Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Strides Emerging Markets Limited

Open charges
None
Satisfied charges
₹15 Cr
Breakdown by lending institutions
Yes Bank Limited₹15.00 Cr
Latest charge details
DateLenderAmountStatus
19 Feb 2015Yes Bank Limited₹15 CrSatisfied

Total charge records: 1 View all charges

Employees and EPFO Compliance at Strides Emerging Markets Limited

Strides Emerging Markets Limited has a workforce of 199 employees as of Apr 09, 2024.

Employee count
199
Active EPFO establishments
1
Employee growth
17.75%
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

CIN History of Strides Emerging Markets Limited

Strides Emerging Markets has one previous CIN (Corporate Identification Number): U24132KA2012PTC064214. The current CIN is U24132KA2012PLC064214, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24132KA2012PLC064214Current
U24132KA2012PTC064214Previous

Recent Activity on Strides Emerging Markets Limited

Strides Emerging Markets Limited has 10 board changes on record since 2016: 3 appointments and 7 cessations. The latest: Akhilesh Kumar Balakrishna Pillai ceased to be Director on 29 Nov 2018.

AGM
Strides Emerging Markets Limited last Annual general meeting of members was held on 23 Sep 2020 as per latest MCA records.
Filing
Strides Emerging Markets Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Bangalore.
Ceased
Akhilesh Kumar Balakrishna Pillai ceased to be Director.
Ceased
Krishnan Tirucherai Parthasarathy ceased to be Additional Director.
Charges
A charge registered on 19 Feb 2015 via Charge ID 10554026 with Yes Bank Limited was fully satisfied on 06 Jul 2018.
Ceased
Sunil Sadanand Nadkarni ceased to be Director.
Appointed
Krishnan Tirucherai Parthasarathy was appointed as Director.
Ceased
Sudhir Krishna Kanchan ceased to be Director.
Ceased
Sinhue Bosco Noronha ceased to be Director.
Ceased
Umesh Pralhadrao Kale ceased to be Additional Director.
Ceased
Venkata Seetharama Raju Pakalapati ceased to be Additional Director.
Appointed
Umesh Pralhadrao Kale was appointed as Director.

4 earlier events are listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts for Strides Emerging Markets Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Strides Emerging Markets Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Strides Emerging Markets Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Strides Emerging Markets Limited

Strides Emerging Markets has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
29AARCS5667D1ZQKarnatakaActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Strides Emerging Markets Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Strides Emerging Markets Limited

Strides Emerging Markets has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.

Strides Emerging Markets was a public limited company based in Bangalore, Karnataka, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 01 June 2012 and is registered under CIN U24132KA2012PLC064214. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.

Strides Emerging Markets was incorporated on 01 June 2012. It is registered with the Registrar of Companies, Bangalore.

Strides Emerging Markets had 3 directors:

The CIN (Corporate Identification Number) of Strides Emerging Markets is U24132KA2012PLC064214. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The registered office of Strides Emerging Markets is at Strideshouse Bilekahalli Bannerghattaroad, Bangalore, Karnataka, India – 560076.

Strides Emerging Markets can be reached through the website strides.com. Its registered office is in Bangalore, Karnataka, India.

Strides Emerging Markets reported revenue of ₹39.32 Cr for FY 2020 (up 735% YoY).

Strides Emerging Markets has an authorised share capital of ₹10 Cr and a paid-up capital of ₹5.63 Cr.

Strides Emerging Markets reported a net profit of ₹8.54 Cr (net margin 21.7%) and EBITDA of -₹5.55 Cr (EBITDA margin -14.1%) for FY 2020, as per its filed financial statements.

The GSTIN of Strides Emerging Markets is 29AARCS5667D1ZQ, registered in Karnataka.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available